Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALPN |
---|---|---|
09:32 ET | 31448 | 64.955 |
09:34 ET | 5658 | 64.955 |
09:36 ET | 10194 | 64.95 |
09:38 ET | 2000 | 64.95 |
09:39 ET | 3500 | 64.955 |
09:41 ET | 1803 | 64.955 |
09:43 ET | 400 | 64.95 |
09:45 ET | 4203 | 64.955 |
09:48 ET | 2998 | 64.96 |
09:50 ET | 53363 | 64.96 |
09:52 ET | 500 | 64.96 |
09:54 ET | 11975 | 64.965 |
09:56 ET | 500 | 64.97 |
09:57 ET | 1900 | 64.97 |
09:59 ET | 6919 | 64.97 |
10:01 ET | 715 | 64.97 |
10:03 ET | 25421 | 64.97 |
10:06 ET | 5250 | 64.97 |
10:08 ET | 2023 | 64.97 |
10:10 ET | 1207 | 64.97 |
10:12 ET | 600 | 64.97 |
10:14 ET | 1097 | 64.97 |
10:15 ET | 1427 | 64.965 |
10:17 ET | 1300 | 64.97 |
10:19 ET | 100 | 64.965 |
10:21 ET | 400 | 64.97 |
10:24 ET | 900 | 64.97 |
10:26 ET | 17453 | 64.98 |
10:28 ET | 1600 | 64.975 |
10:30 ET | 1716 | 64.975 |
10:32 ET | 2216 | 64.975 |
10:33 ET | 400 | 64.98 |
10:35 ET | 600 | 64.98 |
10:37 ET | 2693 | 64.975 |
10:39 ET | 2414 | 64.97 |
10:42 ET | 200 | 64.975 |
10:44 ET | 1081 | 64.975 |
10:46 ET | 5640 | 64.975 |
10:48 ET | 206 | 64.975 |
10:50 ET | 2707 | 64.975 |
10:51 ET | 1678 | 64.98 |
10:53 ET | 616 | 64.98 |
10:55 ET | 200 | 64.975 |
10:57 ET | 300 | 64.98 |
11:00 ET | 1700 | 64.97 |
11:02 ET | 1408 | 64.975 |
11:06 ET | 632 | 64.975 |
11:08 ET | 2100 | 64.975 |
11:09 ET | 1819 | 64.98 |
11:11 ET | 2093 | 64.975 |
11:13 ET | 2782 | 64.975 |
11:15 ET | 1324 | 64.975 |
11:18 ET | 2245 | 64.98 |
11:20 ET | 1400 | 64.98 |
11:22 ET | 1570 | 64.975 |
11:24 ET | 1200 | 64.98 |
11:26 ET | 300 | 64.975 |
11:27 ET | 100 | 64.98 |
11:29 ET | 3066 | 64.98 |
11:31 ET | 2131 | 64.98 |
11:33 ET | 200 | 64.975 |
11:36 ET | 6532 | 64.975 |
11:38 ET | 2718 | 64.98 |
11:40 ET | 11736 | 64.98 |
11:42 ET | 3018 | 64.975 |
11:44 ET | 2604 | 64.975 |
11:45 ET | 2100 | 64.975 |
11:47 ET | 1574 | 64.975 |
11:51 ET | 4054 | 64.971 |
11:54 ET | 2985 | 64.97 |
11:56 ET | 1294 | 64.975 |
11:58 ET | 1400 | 64.97 |
12:00 ET | 300 | 64.975 |
12:02 ET | 3189 | 64.97 |
12:03 ET | 5240 | 64.97 |
12:05 ET | 8927 | 64.97 |
12:07 ET | 4631 | 64.97 |
12:12 ET | 1100 | 64.97 |
12:14 ET | 4337 | 64.975 |
12:16 ET | 2098 | 64.98 |
12:18 ET | 1200 | 64.97 |
12:20 ET | 3649 | 64.97 |
12:21 ET | 1627 | 64.97 |
12:25 ET | 1300 | 64.9702 |
12:27 ET | 3610 | 64.975 |
12:30 ET | 2128 | 64.97 |
12:32 ET | 1410 | 64.97 |
12:34 ET | 200 | 64.975 |
12:36 ET | 836 | 64.97 |
12:38 ET | 300 | 64.975 |
12:39 ET | 100 | 64.97 |
12:41 ET | 400 | 64.975 |
12:43 ET | 347 | 64.97 |
12:45 ET | 6314 | 64.96 |
12:48 ET | 300 | 64.96 |
12:50 ET | 732 | 64.96 |
12:52 ET | 200 | 64.96 |
12:54 ET | 400 | 64.965 |
12:56 ET | 372 | 64.96 |
12:57 ET | 100 | 64.965 |
12:59 ET | 200 | 64.965 |
01:01 ET | 51018 | 64.97 |
01:03 ET | 300 | 64.96 |
01:06 ET | 300 | 64.97 |
01:08 ET | 231 | 64.97 |
01:10 ET | 700 | 64.965 |
01:12 ET | 100 | 64.97 |
01:14 ET | 403 | 64.97 |
01:15 ET | 1428 | 64.97 |
01:17 ET | 100 | 64.965 |
01:19 ET | 100 | 64.97 |
01:21 ET | 500 | 64.965 |
01:24 ET | 2229 | 64.97 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alpine Immune Sciences Inc | 4.5B | -95.0x | --- |
Krystal Biotech Inc | 4.7B | 87.0x | --- |
Immunovant Inc | 4.5B | -17.0x | --- |
Madrigal Pharmaceuticals Inc | 4.5B | -9.3x | --- |
Nuvalent Inc | 4.6B | -30.4x | --- |
Crinetics Pharmaceuticals Inc | 4.0B | -13.6x | --- |
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which is engaged in discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company’s approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its ALPN-303 (povetacicept) is a dual antagonist of the B cell activating factor (BAFF) and a proliferation, inducing ligand (APRIL), cytokines, which play key roles in the pathogenesis of multiple autoimmune diseases via their contribution to the activation, differentiation and/or survival of B cells, particularly antibody-secreting cells, as well as T cells and innate immune cells. Its ALPN-101 (acazicolcept) is a dual Inducible T cell Costimulator (ICOS), and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.5B |
---|---|
Revenue (TTM) | $56.5M |
Shares Outstanding | 68.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-0.68 |
Book Value | $5.43 |
P/E Ratio | -95.0x |
Price/Sales (TTM) | 78.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -90.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.